Clinical Trials Logo

Generalized Myasthenia Gravis clinical trials

View clinical trials related to Generalized Myasthenia Gravis.

Filter by:

NCT ID: NCT04202341 Recruiting - Clinical trials for Generalized Myasthenia Gravis

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Start date: December 2, 2019
Phase:
Study type: Observational [Patient Registry]

Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT) such as eculizumab (Soliris®) and ravulizumab (Ultomiris®).